ZA9610888B - Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads - Google Patents

Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads

Info

Publication number
ZA9610888B
ZA9610888B ZA9610888A ZA9610888A ZA9610888B ZA 9610888 B ZA9610888 B ZA 9610888B ZA 9610888 A ZA9610888 A ZA 9610888A ZA 9610888 A ZA9610888 A ZA 9610888A ZA 9610888 B ZA9610888 B ZA 9610888B
Authority
ZA
South Africa
Prior art keywords
controlled release
release beads
furosemide
formulation containing
pharmaceutical
Prior art date
Application number
ZA9610888A
Inventor
Hans G Arwidsson
Lars J Stubberud
Maria Eriksson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA9610888B publication Critical patent/ZA9610888B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9610888A 1996-01-05 1996-12-23 Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads ZA9610888B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9600046A SE9600046D0 (en) 1996-01-05 1996-01-05 New pharmaceutical formulation

Publications (1)

Publication Number Publication Date
ZA9610888B true ZA9610888B (en) 1997-07-07

Family

ID=20400947

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9610888A ZA9610888B (en) 1996-01-05 1996-12-23 Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads

Country Status (7)

Country Link
AU (1) AU1323897A (en)
HR (1) HRP970004A2 (en)
MA (1) MA26416A1 (en)
SE (1) SE9600046D0 (en)
TN (1) TNSN97001A1 (en)
WO (1) WO1997025028A1 (en)
ZA (1) ZA9610888B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070051953A (en) 1998-11-02 2007-05-18 엘란 코포레이션, 피엘씨 Multiparticulate modified release composition
FR2796840B1 (en) 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques LOW-DOSE TABLETS AND METHOD OF PREPARATION
HU230828B1 (en) 1999-10-29 2018-08-28 Euro Celtique Sa Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
CN101317825A (en) 2000-10-30 2008-12-10 欧罗赛铁克股份有限公司 Controlled release hydrocodone formulations
US20030091633A1 (en) * 2001-11-15 2003-05-15 John Kelly Methods and compositions for use of (S)-bisoprolol
IL160095A0 (en) * 2004-01-28 2004-06-20 Yissum Res Dev Co Formulations for poorly soluble drugs
EP1669074B1 (en) * 2004-12-01 2010-06-02 Par Pharmaceuticals, Inc. Use of megestrol acetate for improving heart function and the treatment of heart insufficiency
WO2009145716A1 (en) * 2008-05-28 2009-12-03 Astrazeneca Ab New pharmaceutical formulation useful in gerd therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
CA1338596C (en) * 1988-09-27 1996-09-17 Hiroyoshi Koyama Granules having core and their production

Also Published As

Publication number Publication date
SE9600046D0 (en) 1996-01-05
WO1997025028A1 (en) 1997-07-17
HRP970004A2 (en) 1998-04-30
AU1323897A (en) 1997-08-01
MA26416A1 (en) 2004-12-20
TNSN97001A1 (en) 2005-03-15

Similar Documents

Publication Publication Date Title
IL114448A0 (en) New beads for controlled release and a pharmaceutical preparation containing the same
ZA985618B (en) Sulfonamide compounds and pharmaceutical use thereof
EP0858334A4 (en) Analgesic immediate and controlled release pharmaceutical composition
GB9407386D0 (en) Pharmaceutical formulation
GB9402203D0 (en) Pharmaceutical formulation
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
NZ288997A (en) Controlled release pharmaceutical formulation comprising polypeptide encapsulated in alginate
IL112521A0 (en) Pharmaceutical formulation
IL116673A0 (en) A pharmaceutical composition containing a benzimidazole derivative and processes for the preparation thereof
GB9519363D0 (en) Pharmaceutical formulation
AP9801173A0 (en) Rapidly releasing and taste-making pharmaceutical dosage
AP9901623A0 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
HUP9904335A3 (en) Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
EP0862431A4 (en) Pharmaceutical formulation
IL125820A0 (en) Therapeutic agent for diabetes and a pharmaceutical composition containing the same
ZA958606B (en) A pharmaceutical formulation
GB9405856D0 (en) Pharmaceutical formulation
IL125775A0 (en) Use of a zwitterion composition and a pharmaceutical composition containing the same
ZA9610888B (en) Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads
AU6422298A (en) Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
HUP9701618A3 (en) Pharmaceutical composition containing tramadol and a calcium-canal-antagonist
AU3709897A (en) Cathecol derivatives and a method for the preparation thereof and a pharmaceutical composition containing the same
AU8031698A (en) Indane compounds and their pharmaceutical use
AU7681498A (en) Pharmaceutical composition and use thereof
HUP9602220A3 (en) Substituted 4h-piranes and pharmaceutical preparations containing them